Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$687,057,877
-$24,863,800 QoQ
Shares Held
1,897,321
-6.2% QoQ
Ownership
0.351%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#35
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 27%
None 73%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. AMGN ranks #8 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
This page
|
1,897,321 | $687,057,877 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $687,057,877 | 1,897,321 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $711,921,677 | 2,023,367 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $663,530,684 | 2,027,224 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $564,666,960 | 2,000,946 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $689,078,829 | 2,467,959 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $661,332,478 | 2,122,717 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $528,021,712 | 2,025,866 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $625,647,398 | 1,941,738 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $607,391,236 | 1,943,963 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $561,417,416 | 1,974,597 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $624,106,216 | 2,166,885 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $571,778,297 | 2,127,468 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $454,211,400 | 2,045,813 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $446,042,768 | 1,845,058 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $500,456,840 | 1,905,486 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $368,225,384 | 1,633,653 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $408,687,063 | 1,679,766 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $425,726,525 | 1,760,510 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $407,010,547 | 1,809,177 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $273,315,427 | 1,285,283 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $356,272,310 | 1,461,630 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $358,987,793 | 1,442,819 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $316,235,414 | 1,375,415 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $405,240,835 | 1,594,432 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $359,489,319 | 1,524,164 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $363,126,729 | 1,791,184 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||